Adaptive Biotechnologies (ADPT) News Today → Are You Positioned For The New Energy Goldrush? (From Wealthpin Pro) (Ad) Free ADPT Stock Alerts $3.45 -0.16 (-4.43%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 2 at 5:26 AM | marketbeat.comPrincipal Financial Group Inc. Has $2.41 Million Holdings in Adaptive Biotechnologies Co. (NASDAQ:ADPT)Principal Financial Group Inc. cut its holdings in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 60.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 492,119 shares of the company's stock after sJune 1 at 7:38 AM | americanbankingnews.comAdaptive Biotechnologies Co. (NASDAQ:ADPT) Sees Large Increase in Short InterestJune 1 at 7:34 AM | marketbeat.comAdaptive Biotechnologies Co. (NASDAQ:ADPT) Short Interest Up 9.1% in MayAdaptive Biotechnologies Co. (NASDAQ:ADPT - Get Free Report) was the target of a significant increase in short interest during the month of May. As of May 15th, there was short interest totalling 13,140,000 shares, an increase of 9.1% from the April 30th total of 12,040,000 shares. Based on an average trading volume of 1,660,000 shares, the short-interest ratio is presently 7.9 days.May 31 at 7:38 AM | americanbankingnews.comAdaptive Biotechnologies (NASDAQ:ADPT) Shares Gap Down to $3.65May 31 at 7:30 AM | globenewswire.comAdaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clonoSEQ® To Be Presented at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid CongressMay 29, 2024 | globenewswire.comAdaptive Biotechnologies to Participate in the Goldman Sachs 45th Annual Global Healthcare ConferenceMay 28, 2024 | marketbeat.comAdaptive Biotechnologies (NASDAQ:ADPT) Trading 6.4% Higher Adaptive Biotechnologies (NASDAQ:ADPT) Trading Up 6.4%May 25, 2024 | finance.yahoo.comARK Invest's Cathie Wood Snags These 3 Bargains — Are They Right for Your Portfolio?May 24, 2024 | insidermonkey.comDoes Adaptive Biotechnologies Corporation (ADPT) Have Strong Growth Potential?May 24, 2024 | americanbankingnews.comAdaptive Biotechnologies Co. (NASDAQ:ADPT) Receives Average Rating of "Moderate Buy" from AnalystsMay 24, 2024 | marketbeat.comAdaptive Biotechnologies Co. (NASDAQ:ADPT) Given Consensus Rating of "Moderate Buy" by BrokeragesAdaptive Biotechnologies Co. (NASDAQ:ADPT - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the six brokerages that are covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold rating and four have given a buy ratingMay 23, 2024 | bizjournals.comAdaptive Sports Northwest's Jen Armbruster on making businesses more inclusive to those with disabilitiesMay 23, 2024 | investorplace.comMighty Mites: 3 Small-Cap Stocks Packing a Powerful PunchMay 22, 2024 | venturebeat.comSkymel’s NeuroSplit™ Adaptive Inferencing Lets AI Companies Run the Latest GenAI Models – Even on Older GPUsMay 22, 2024 | fool.comCathie Wood Goes Bargain Hunting: 3 Stocks She Just BoughtMay 19, 2024 | marketbeat.comAdaptive Biotechnologies Co. (NASDAQ:ADPT) Shares Bought by Massachusetts Financial Services Co. MAMassachusetts Financial Services Co. MA increased its position in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 32.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,603,500 shares of the companyMay 16, 2024 | marketbeat.comAdaptive Biotechnologies (NASDAQ:ADPT) Trading Down 3.8%Adaptive Biotechnologies (NASDAQ:ADPT) Trading Down 3.8%May 15, 2024 | finance.yahoo.comAdaptive Biotechnologies Corporation (ADPT)May 9, 2024 | finance.yahoo.comAdaptive Biotechnologies First Quarter 2024 Earnings: Beats ExpectationsMay 9, 2024 | msn.comAdaptive Surf Championships return to Waikiki welcoming athletes from 18 countriesMay 8, 2024 | fool.comWhy Adaptive Biotechnologies Topped the Market TodayMay 8, 2024 | finance.yahoo.comAdaptive Biotechnologies Corporation (NASDAQ:ADPT) Q1 2024 Earnings Call TranscriptMay 8, 2024 | marketbeat.comAdaptive Biotechnologies (NASDAQ:ADPT) Shares Gap Up Following Earnings BeatAdaptive Biotechnologies (NASDAQ:ADPT) Shares Gap Up on Earnings BeatMay 8, 2024 | marketbeat.comAdaptive Biotechnologies (NASDAQ:ADPT) Issues Quarterly Earnings ResultsAdaptive Biotechnologies (NASDAQ:ADPT - Get Free Report) posted its earnings results on Tuesday. The company reported ($0.33) earnings per share for the quarter, beating analysts' consensus estimates of ($0.35) by $0.02. The company had revenue of $41.87 million for the quarter, compared to analyst estimates of $38.78 million. Adaptive Biotechnologies had a negative return on equity of 53.65% and a negative net margin of 132.29%. The company's revenue for the quarter was up 11.2% on a year-over-year basis. During the same quarter last year, the company earned ($0.40) earnings per share.May 8, 2024 | finance.yahoo.comAdaptive Biotechnologies Corp (ADPT) Q1 2024 Earnings Call Transcript Highlights: Strategic ...May 8, 2024 | msn.comADPT Stock Earnings: Adaptive Biotechnologies Beats EPS, Beats Revenue for Q1 2024May 7, 2024 | seekingalpha.comAdaptive Biotechnologies Corporation 2024 Q1 - Results - Earnings Call PresentationMay 7, 2024 | finance.yahoo.comAdaptive Biotechnologies: Q1 Earnings SnapshotMay 7, 2024 | markets.businessinsider.comAdaptive Biotechnologies Q1 Loss decreases, beats estimatesMay 7, 2024 | finance.yahoo.comAdaptive Biotechnologies Q1 2024 Earnings: Revenue Beats Estimates Amidst ChallengesMay 7, 2024 | globenewswire.comAdaptive Biotechnologies Reports First Quarter 2024 Financial ResultsMay 1, 2024 | tmcnet.comHITRUST Enhances Cyber Threat Adaptive Engine Using Microsoft Azure OpenAI Service and Microsoft Defender Threat IntelligenceMay 1, 2024 | finance.yahoo.comNetenrich Launches Adaptive MDR™ for Google Chronicle Security Operations, Powered by Resolution Intelligence Cloud™ TechnologyApril 30, 2024 | msn.comUniversity of Arizona Adaptive Athletic Department receives $1 million donationApril 28, 2024 | marketbeat.comabrdn plc Invests $4.58 Million in Adaptive Biotechnologies Co. (NASDAQ:ADPT)abrdn plc purchased a new position in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 933,794 shares of the company's stock, valApril 24, 2024 | msn.comFizik Antares Adaptive Reshapes Saddle that Started Fizik’s 3D-Printed Padding BoomApril 24, 2024 | finance.yahoo.comAdaptive Shield Launches Fast Forward Partner Program to Help Enterprises Secure the SaaS EcosystemApril 17, 2024 | globenewswire.comAdaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024April 16, 2024 | bizjournals.comAdaptive Biotechnologies names new CFO, restructures business linesApril 15, 2024 | marketbeat.comAdaptive Biotechnologies Co. (NASDAQ:ADPT) Short Interest UpdateAdaptive Biotechnologies Co. (NASDAQ:ADPT - Get Free Report) was the target of a significant growth in short interest during the month of March. As of March 31st, there was short interest totalling 9,100,000 shares, a growth of 7.6% from the March 15th total of 8,460,000 shares. Approximately 6.6% of the company's stock are short sold. Based on an average daily volume of 1,490,000 shares, the days-to-cover ratio is currently 6.1 days.April 13, 2024 | msn.comAdaptive Foundation offers free fitness classes for veterans, first responders in TylerApril 9, 2024 | msn.comThe Center for Adaptive Riding hosts open house for new locationApril 4, 2024 | marketbeat.comAdaptive Biotechnologies Co. (NASDAQ:ADPT) Given Average Rating of "Moderate Buy" by AnalystsAdaptive Biotechnologies Co. (NASDAQ:ADPT - Get Free Report) has received an average rating of "Moderate Buy" from the five brokerages that are presently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold rating and three have given a buy rating tApril 4, 2024 | marketbeat.comAdaptive Biotechnologies (NASDAQ:ADPT) PT Lowered to $5.00 at BTIG ResearchBTIG Research lowered their target price on Adaptive Biotechnologies from $6.00 to $5.00 and set a "buy" rating for the company in a report on Thursday.April 4, 2024 | uk.investing.comAdaptive Biotechnologies CFO resigns, successor namedApril 2, 2024 | marketwatch.comAdaptive Biotechnologies to Restructure Businesses After ReviewApril 2, 2024 | globenewswire.comAdaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 RevenueApril 1, 2024 | msn.comCenter for Adaptive Riding hosts open house at new facilityMarch 30, 2024 | msn.comLocal family hosts ‘Adaptive Easter Egg Hunt’March 28, 2024 | finance.yahoo.comNetcracker Continues Its Support of the U.S. Paralympic Ski and Snowboard Team at Adaptive Spirit 2024 Get Adaptive Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for ADPT and its competitors with MarketBeat's FREE daily newsletter. Email Address This military-backed stock “owns” AI market (Ad)The AI boom is just getting started. And the real wealth has still to be made… You must read this new presentation from Porter Stansberry. ADPT Media Mentions By Week ADPT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ADPT News Sentiment▼0.500.76▲Average Medical News Sentiment ADPT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ADPT Articles This Week▼83▲ADPT Articles Average Week Get Adaptive Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for ADPT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Kodiak Sciences News Today Kymera Therapeutics News Today Beam Therapeutics News Today Fusion Pharmaceuticals News Today Sana Biotechnology News Today Neumora Therapeutics News Today Vir Biotechnology News Today Cullinan Therapeutics News Today BioCryst Pharmaceuticals News Today Tarsus Pharmaceuticals News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ADPT) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressBiden Nomination CANCELED?The Freeport SocietyBuy this small stock before coming AI Tidal WaveChaikin AnalyticsWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adaptive Biotechnologies Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.